Stock Scorecard
Stock Summary for Utah Medical Products Inc (UTMD) - $53.60 as of 5/10/2025 12:44:22 PM EST
Total Score
16 out of 30
Safety Score
47 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for UTMD
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for UTMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for UTMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for UTMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for UTMD (47 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 0 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for UTMD
Financial Details for UTMD
Company Overview |
|
|---|---|
| Ticker | UTMD |
| Company Name | Utah Medical Products Inc |
| Country | USA |
| Description | Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/23/2025 |
Stock Price History |
|
| Last Day Price | 53.60 |
| Price 4 Years Ago | 95.16 |
| Last Day Price Updated | 5/10/2025 12:44:22 PM EST |
| Last Day Volume | 9,420 |
| Average Daily Volume | 18,490 |
| 52-Week High | 76.21 |
| 52-Week Low | 51.26 |
| Last Price to 52 Week Low | 4.56% |
Valuation Measures |
|
| Trailing PE | 14.14 |
| Industry PE | 48.91 |
| Sector PE | 47.92 |
| 5-Year Average PE | 27.89 |
| Free Cash Flow Ratio | 2.11 |
| Industry Free Cash Flow Ratio | 39.21 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 22.29 |
| Total Cash Per Share | 25.39 |
| Book Value Per Share Most Recent Quarter | 35.67 |
| Price to Book Ratio | 1.51 |
| Industry Price to Book Ratio | 5.21 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 4.48 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 3,281,800 |
| Market Capitalization | 175,904,480 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 6/16/2025 |
| Previous Dividend Amount | 0.3050 |
| Current Dividend Amount | 0.3050 |
| Total Years Dividend Increasing | 3 |
| Trailing Annual Dividend Rate | 1.21 |
| Trailing Annual Dividend Yield | 2.24% |
| Forward Annual Dividend Rate | 1.22 |
| Forward Annual Dividend Yield | 2.26% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 1.97% |
| 5-Year Average Dividend Yield | 1.51% |
| 1-Year Dividend Growth Rate Percentage | 1.24% |
| 3-Year Dividend Growth Rate Percentage | 0.62% |
| 5-Year Dividend Growth Rate Percentage | 2.05% |
| All-Time Dividend Growth Rate Percentage | 3.89% |
| Dividend Payout Ratio | 31.93% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -15.70% |
| Annual Earnings Growth | -16.60% |
| Reported EPS 12 Trailing Months | 3.79 |
| Reported EPS Past Year | 0.92 |
| Reported EPS Prior Year | 3.95 |
| Net Income Twelve Trailing Months | 12,959,000 |
| Net Income Past Year | 13,874,000 |
| Net Income Prior Year | 16,635,000 |
| Quarterly Revenue Growth YOY | -14.40% |
| 5-Year Revenue Growth | -2.70% |
| Operating Margin Twelve Trailing Months | 35.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 83,325,000 |
| Total Cash Past Year | 82,976,000 |
| Total Cash Prior Year | 92,868,000 |
| Net Cash Position Most Recent Quarter | 83,325,000 |
| Net Cash Position Past Year | 82,976,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 117,427,000 |
| Total Stockholder Equity Prior Year | 128,313,000 |
| Total Stockholder Equity Most Recent Quarter | 117,540,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 14,548,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.43 |
| Free Cash Flow Past Year | 14,596,000 |
| Free Cash Flow Prior Year | 21,642,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.68 |
| MACD Signal | -0.99 |
| 20-Day Bollinger Lower Band | 50.86 |
| 20-Day Bollinger Middle Band | 57.77 |
| 20-Day Bollinger Upper Band | 64.68 |
| Beta | 0.30 |
| RSI | 51.77 |
| 50-Day SMA | 76.74 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 79.33 |
System |
|
| Modified | 5/10/2025 12:44:25 PM EST |